Syros Pharmaceuticals Inc. (SYRS)
Market Closed
19 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
LSE $
0. 00
-0
-75%
$
10.73K Market Cap
4.89 P/E Ratio
- Div Yield
6,918 Volume
-4.76 Eps
$ 0
Previous Close Analysts:
Want to track SYRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Syros Pharmaceuticals Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MB Mark Breidenbach Oppenheimer | -92,174.02 | $330,595.93 | - | $330,595.93 | 100% |
